Urgent need for prostate cancer screening amongst Dutch men

September 15, 2010, European Association of Urology

A recent TNS NIPO survey, on behalf of the Dutch Association of Urology (NVU) and the European Association of Urology (EAU), showed that almost four out of 10 Dutch men of 50 years and older suffer, or have suffered, from urinary complaints. The same number of men also said in the same survey they are worried that they may have prostate cancer.

The TNS NIPO survey also indicated that a significantly larger number of men that suffer, or have suffered, from urinary complaints expressed the concern of having prostate cancer as compared to men without urinary complaints. Hundreds of thousands of men suffer from prostate complaints, however, many of them often do not seek medical help because they see them as a normal part of growing older or because their complaints do not hamper them in daily life.

Of note was the survey finding that practically all men who have participated in the Dutch study said that they would prefer to have an annual check or screening for . The widely used screening called the Prostate-Specific Antigen (PSA) test, however, is not known to the vast majority of survey participants. The conclusion is that reliable information is urgently needed.

The study results will be released today, 15 September, during the annual official European prostate awareness day, part of the ongoing Urology Week activities. The Dutch and European associations for urologists (NVU and EAU) are collaborating to inform people about the prostate and the most common prostate-related diseases that affect many .

Related Stories

Recommended for you

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

Kinase inhibitor larotrectinib shows durable anti-tumor abilities

February 21, 2018
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors ...

Similarities found in cancer initiation in kidney, liver, stomach, pancreas

February 21, 2018
Recent research at Washington University School of Medicine in St. Louis demonstrated that mature cells in the stomach sometimes revert back to behaving like rapidly dividing stem cells. Now, the researchers have found that ...

Research could change how doctors treat leukemia and other cancers fed by fat

February 21, 2018
Obesity and cancer risk have a mysterious relationship, with obesity increasing the risk for 13 types of cancer. For some cancers—including pediatric cancers—obesity affects survival rates, which are lower for people ...

New technique predicts gene resistance to cancer treatments

February 21, 2018
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.